A B S T R A C T We previously demonstrated an alternate pathway for the biosynthesis of 5-aminolevulinic acid (ALA) in bovine liver mitochondria and of tetrapyrroles in suspensions of rat hepatocytes (1980. J. Biol. Chem. 255: 3742;. Proc. Natl. Acad. Sci. USA. 78: 5335). This pathway involves a transamination reaction that incorporates the intact 5-carbon skeleton of 4,5-dioxovaleric acid (DOVA) into ALA.
INTRODUCTION
5-Aminolevulinic acid (ALA)' is the first committed precursor in the biosynthesis of tetrapyrroles (1, 2) . It has generally been accepted that the generation of ALA occurs exclusively by the condensation of succinyl coenzyme (Co)-A and glycine in a reaction catalyzed by the enzyme ALA synthase, EC 2.3.1.37 (ALA synthase) (1, 2) (Fig. 1A) .
Recently several lines of evidence have suggested that in some biologic systems ALA may be synthesized by enzymic reactions that differ from the classical condensation reaction. For example, green plants require ALA for the biosynthesis of chlorophyll, but have no demonstrable ALA synthase activity (3, 4) . They appear to synthesize ALA via a transamination reaction in which the intact 5-carbon skeleton of a precursor compound serves as the amino acceptor (5) . Similar transamination reactions have also been demonstrated in algae and bacteria (6, 7) . We recently reported the isolation and characterization of an enzyme from bovine liver mitochondria that synthesizes ALA by a transamination reaction (8, 9) . This enzyme, L-alanine: 4,5-dioxovaleric acid aminotransferase, catalyzes a transamination reaction between L-alanine and 4,5-dioxovalerate (DOVA), yielding ALA and pyruvate (Fig. 1B) . The capacity of the L-alanine: DOVA aminotransferase reaction to synthesize ALA appeared to exceed that of the ALA synthase reaction (8) . Finally, we have presented in vitro evidence for the conversion of DOVA to porphyrins and heme in suspensions of intact, respiring rat hepatocytes (10) .
In this report, we present evidence for the in vivo conversion of DOVA into ALA and heme in the rat. Quantification of DOVA. Both radiolabeled and unlabeled DOVA were quantified by reaction with o-phenylenediamine as described by Jerzykowski et al. (12) . DOVA excreted in urine was quantified as the benzoquinoxaline derivative by the method of Porra et al. (13 Isolation and quantification of urinary ALA. Urine was adjusted to pH 7.0 with 3 N NaOH and then passed sequentially through prepacked stackable columns containing AG 1-X8 and AG 50W-X4. Porphobilinogen is adsorbed on AG 1-X8 and ALA is adsorbed on AG 50W-X4. The AG 50W-X4 was washed free of contaminating DOVA with 50 ml H20 and the ALA was eluted by the method of Marver et al. (14) . The eluted ALA was quantified spectrophotometrically after conversion to the 2-methyl-3-carbethoxy-4-(3-propionic acid) pyrrole by the method of Mauzerall and Granick (15) . When radiolabeled ALA was employed, the specific activity of the isolated ALA was determined by liquid scintillation counting. Purity of the isolated radiolabeled ALA was verified by paper chromatography with two different solvent systems: phenol saturated with H20 (Rf for ALA = 0.34) and N-butyl alcohol:glacial acetic. acid:water (50:25:25, vol:vol:vol) (Rf for ALA = 0.45) (16) .
Induction of hemolytic anemia. A 0.4% solution of filter sterilized phenylhydrazine was adjusted to pH 6.8 and intraperitoneal injections of 0.04 mg/g body wt were administered. Injections were repeated 24 and 32 h later; 144 h after the first injection, rats were used for experimentation. At this point reticulocyte counts averaged 30% and the spleen weights had increased fourfold. Histologic sections of the spleen revealed that erythroid precursors (normoblasts) were the predominant cells present.
Isolation and quantification of hepatic and erythroid heme. 3 h after intraperitoneal injections of either [5- 14C]DOVA, [2-14C] (17) . Heme radioactivity was determined by liquid scintillation counting. Quenching was avoided by decolorizing the heme solutions with H202 and waiting 24 h for the decay of chemiluminescence.
Purity of the isolated radiolabeled heme was verified by removal of the iron by the method of Grinstein (18) . The protoporphyrin dimethyl ester was isolated by thin-layer chromatography on silica with a developing system of chloroform:petroleum ether (5:2, vol:vol) and eluted with dichloromethane:methanol (10:1, vol:vol). The protoporphyrin dimethyl ester was quantified spectrophotometrically and the radioactivity determined by liquid scintillation counting. The specific activity (disintegrations per minute per mole) of the protoporphyrin dimethyl ester was the same as that of the starting heme.
RESULTS
Verification of the chromatographic separation of ALA from DOVA. To verify our ability to separate ALA and DOVA in rat urine, 100 .tmol of [5-'4C]DOVA (sp act 110 dpm/,umol) and 180 Mmol of ALA were added to aliquots of acidified rat urine. The urine was neutralized and immediately passed through a prepacked column containing AG 50W-X4 (see Methods). The DOVA was not retained on the AG 50W-X4. The ALA was eluted from the AG 50W-X4 with 0.5 M sodium acetate and quantified as the Ehrlich chromophore. The recovery of ALA approximated 99% and there was no radioactivity in the eluant.
To verify that higher concentrations of DOVA were not retained on AG 50W-X4, [5- (8) .
Evidence that DOVA could be converted into ALA in vivo was first presented by Kissel and Heilmeyer (19) . They injected unlabeled DOVA into rats and observed an increase in the excretion of ALA in the urine. Because unlabeled DOVA was used, it was not possible to conclude that the intact 5-carbon skeleton of DOVA had been incorporated into the ALA excreted in the urine. In our experiments [5-'4C]DOVA was used. The detection of the radiolabel in ALA (and heme) is strong evidence that the intact 5-carbon skeleton of DOVA has been incorporated into ALA via the transamination reaction we have previously described (Fig. 1B) (8, 9) . Loss of the radiolabeled terminal aldehyde group of [5-'4C]DOVA would result in the generation of succinate. Were the succinate subsequently incorporated into ALA via the classical condensation, unlabeled ALA would be the product.
DOVA, with a carbonyl group three carbon atoms away from a carboxyl group, has the requisite properties expected for inhibitors of ALA dehydrase (20) (21) (22) . Inhibition by DOVA of ALA dehydrase from Clostridium tetanomorphum has been demonstrated (23) and similar results have been obtained in our laboratory with ALA-dehydrase from bovine liver (unpub- (24) (25) (26) (27) .
Studies done in vitro with suspensions of rat hepatocytes demonstrated maximal incorporation of DOVA into tetrapyrroles when the concentration of DOVA in the medium was 0.5-1.0 mM (10) . In an attempt to simulate these conditions in the whole animal, sufficient DOVA was injected to achieve a calculated concentration in total body water of 1 mM. The amount of radiolabeled ALA and glycine injected was calculated to approximate a concentration in cells in the range of the Michaelis constants of these substrates for ALA dehydrase and ALA synthase, respectively. These are rough approximations for several reasons. First, it is likely that the concentration of these compounds in portal blood (and probably in hepatocytes) is initially higher than the concentrations calculated for total body water. Second, these compounds are rapidly excreted in urine.
The quantity of the radiolabeled compounds injected in these experiments far exceeds the trace amounts used in past in vivo studies (28) (29) (30) (31) (32) [5- '4C]DOVA, 0.14% of the radiolabel was recovered as hepatic heme. These data indicate that under the conditions of these experiments, DOVA and glycine are converted to hepatic heme with similar efficiency. Previous in vitro studies suggested that the efficiency of conversion of DOVA to tetrapyrroles was greater than that of glycine (8) . Failure to observe more efficient hepatic utilization of DOVA in the whole-animal experiments is unexplained but may reflect a combination of partial inhibition by DOVA of the cytosolic enzyme ALA dehydrase and differences in permeability between the cell and mitochondrial membranes.
In our studies of erythropoietic heme synthesis in the whole animal, DOVA appeared to be the most efficient substrate. Of the radiolabel injected as [5- '4C]DOVA, 0.35% was recovered as erythroid heme, compared with a recovery of 0.15% of the [4-'4C]ALA and 0.072% of the [2-14C]glycine. The incorporation of labeled ALA into hepatic heme was greater than into erythroid heme (3.4% vs. 0.15%), a difference also observed by other investigators (33) . It has been suggested that differences in membrane permeability to ALA between hepatic and erythroid cells is responsible for this observation (33) .
These studies establish that the intact 5-carbon skeleton of DOVA can be incorporated into ALA and heme in vivo. To establish the physiologic significance of this alternate pathway in mammals will require proof that DOVA is present in mammalian mitochondria. This is an important point, as it has been suggested that Lalanine: DOVA aminotransferase activity is actually a secondary role of a mitochondrial enzyme whose normal function is to generate glycine from glyoxalate (34) . Endogenous DOVA has been demonstrated in algae and bacteria (7, 35) , and it has been suggested that in these organisms DOVA is derived from glutamate or 2-oxoglutarate. These putative precursors are naturally occurring compounds in mammalian mitochondria.
